Lactiplantibacillus plantarum Q180

Product description

Lactiplantibacillus plantarum Q180, researched by CKD BIO, has been clinically proven to lower postprandial blood lipid levels within 12 weeks. This strain can be utilized in various health supplements, including powders and capsules. It is produced in facilities that meet GMP standards and possesses MUI Halal certification.
Read more

Specifications

Products from other suppliers

Lactiplantibacillus plantarum Q180

Contact information

Address

Email

Telephone

Website

View all contact information